Systematic review and meta analysis of 6 quercetin RCTs, showing significantly lower hospitalization and ICU admission. Differences for mortality and recovery were not statistically significant.
2 meta analyses show significant improvements with quercetin for mortality1,
ICU admission1,2, and
hospitalization1,2.
Currently there are 12 quercetin for COVID-19 studies, showing 61% lower mortality [-35‑89%], 89% lower ventilation [-92‑99%], 74% lower ICU admission [29‑90%], 36% lower hospitalization [5‑56%], and 93% fewer cases [73‑98%].
Please send us corrections, updates, or comments.
c19early involves the extraction of 100,000+ datapoints from
thousands of papers. Community updates
help ensure high accuracy.
Treatments and other interventions are complementary.
All practical, effective, and safe
means should be used based on risk/benefit analysis.
No treatment or intervention is 100% available and effective for all current
and future variants.
We do not provide medical advice. Before taking any medication,
consult a qualified physician who can provide personalized advice and details
of risks and benefits based on your medical history and situation. FLCCC and WCH
provide treatment protocols.